The antitumour activity of the prodrug N-l-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts
- 1 September 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (10) , 1602-1606
- https://doi.org/10.1016/s0959-8049(98)00152-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Characterization of novel anthracycline prodrugs activated by human β-glucuronidase for use in antibody-directed enzyme prodrug therapyBiochemical Pharmacology, 1996
- Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.Journal of Clinical Oncology, 1996
- Doxombicin liposome formulation gains marketing approvalAmerican Journal of Health-System Pharmacy, 1996
- Preparation and Characterization of Doxorubicin-Loaded Sterically Stabilized ImmunoliposomesPharmaceutical Research, 1996
- Site-Specific Prodrug Activation by Antibody-.beta.-Lactamase Conjugates: Preclinical Investigation of the Efficacy and Toxicity of Doxorubicin Delivered by Antibody Directed CatalysisBioconjugate Chemistry, 1995
- Cephalosporin Derivatives of Doxorubicin as Prodrugs for Activation by Monoclonal Antibody-.beta.-Lactamase ConjugatesJournal of Medicinal Chemistry, 1995
- Long-circulating (sterically stabilized) liposomes for targeted drug deliveryTrends in Pharmacological Sciences, 1994
- Immunotargeting of Liposomes Containing Lipophilic Antitumor ProdrugsPharmaceutical Research, 1993
- Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestionJournal of Medicinal Chemistry, 1980
- Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity of L1210 leukemic cells in vitro and in vivoJournal of Medicinal Chemistry, 1980